Continuing Education Credits
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
ASTRO designates this live activity for a maximum of 17 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity.
An application to the Commission on Accreditation of Medical Physics Education Program (CAMPEP) has been submitted for Medical Physics Continuing Education Credits (MPCEC).
To be eligible to receive continuing education credit, attendees must complete the online evaluation by Tuesday, January 4, 2022. To access your evaluation, log into ASTRO Academy with your ASTRO credentials. Please only evaluate the sessions you attended.
Certificates of Credit
CME certificates of credit are only available to participants who have completed the online evaluation tool. Participants will have online access to their certificate upon completion of the evaluation. Participants can access, print and save their certificate from ASTRO Academy.
Physicist attendees will not receive certificates of credit from ASTRO. The names of physicist attendees will be sent to CAMPEP 45 days after the meeting.
Disclosure of Vested Interest
ASTRO is an accredited provider of continuing medical education. Since our accreditation is important to us, we plan activities that are compliant with the ACCME and the content or format of CME activities and related materials will promote improvements or quality in health care and not a specific proprietary business interest or commercial bias. Planning Committee members and speakers are required to disclose the existence of any financial or other relationship with the manufacturer(s) or any commercial product(s) or provider(s) of any commercial services discussed in an educational presentation.
Any conflicts of interest are resolved prior to participation. In addition to written disclosure, presenters will disclose any vested interest or their intention to discuss off-label use of pharmaceuticals or devices, if applicable, to the audience at the beginning of their presentation and in accordance with the Accreditation Council for Continuing Medical Education standards and the Food and Drug Administration requirements.
In an effort to increase transparency and easy access to all disclosures, planner and presenter disclosure information will be available online for the 2021 Multidisciplinary Thoracic Cancers Symposium. In addition to being available online, disclosure slides will be shown prior to presentations occurring. Disclosure information will not be printed in paper versions of the meeting materials.
ASTRO is committed to the free exchange of medical education. Inclusion of any presentation in this program, including presentations of off-label uses, does not imply an endorsement by ASTRO of the uses, products or techniques presented.